Similar tenders from other countries.
Showing 1 to 20
Emergency Acquisition Of Material Medicines And Hospital And Dental Inputs * *
20 Feb 2025
25 Feb 2025* Price Registration * Price Registration For Future Acquisition Of Medicines - Hiv/Aids 02. Protocol No. 23.146.702-5
Laboratory Diagnostic System And Reagents For The Execution Of The Confirmation Tests For Hiv 1 And 2, Hcv, Treponema With Immunoblot Technique
Supply of Medicine and Medical / Surgical equipments : Elisa Test kit for detection of HIV P24 antigen\nand antibodies to HIV; HIV 2 and HIV vi sub\ntype „O‟ antigen\n1. Test kit should detect of HIV P24 antigen\nand antibodies to HIV-1 (groups M and O)\nand HIV-2 inhuman serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\npositive and negative controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these\nreagents are kept at 2-6C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/ end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc .
Supply of Medicine and Medical / Surgical equipments : HIV Ag/Ab Combo Reagent for Analyzer\nCMIA technology-based HIV Ag/Ab Combo\nassay for blood donor screening.\nThe reagent kit shall be compatible with\nAlinitys Analyzer. CMIA HIV Ag/Ab Combo 4th\ngeneration assay should use two step\nchemiluminescent microparticle enzyme\nimmunoassay (CMIA) used for the\nsimultaneous qualitative detection of human\nimmunodeficiency virus (HIV) p24 antigen and\nantibodies to HIV type 1 (HIV-1 group M and\ngroup O and/or type 2 (HIV-2) in human serum\nand plasma, including specimens collected\npostmortem (non-heart-beating) to be used on\nAlinity s system for blood donor screening\npurposes. Ready To Use cartridges for the\neasy of use and less manual intervention.\nEach cartridge should be able to perform 500\ntests.\nThe reagent kit must be FDA approved for\nblood donor screening of HIV and certificates\nshall be attached.\nThe reagent kit must be NMRA approved for\nblood donor screening of HIV for blood and\nplasma donors.\nAll certificates of NMRA mentioning donor\nscreening purpose must be submitted for HIV\nAg/Ab Combo reagents.\nThe CMIA technology-based HIV Ag/Ab Combo\nassay should include calibrator kits, control\nkits, release control kits and reaction vessels\nalong with the reagent kits. At the time of\ndelivery expiery time shall be minimum of 10\nmonths.\nPacking : 500 tests etc .
Subject: Electronic Auction - Price Registration For Future Acquisition Of Medicines - Hiv/Aids 01. Protocol No. 23,148,238-5
Object: Electronic Auction - Price Registration For Eventual And Future Acquisition Of Medicines For The Treatment Of Opportunistic Infections, Intended For The State Coordination Of Hiv/Aids, Viral Hepatitis And Sexually Transmitted Infections, With The Objective Of Guaranteeing Assistance To Hiv/Aids Carriers, According To The Conditions, Specifications And Quantities Specified In The Terms Of Reference (Annex I) Of This Notice.
* Price Registry * Price Registry For Future Acquisition Of Medicines - Hiv/Aids 01. Protocol No. 23,148,238-5
* Price Registry * Price Registry For Eventual And Future Acquisition Of Medicines For The Treatment Of Opportunistic Infections, Intended For The State Coordination Of Hiv/Aids, Viral Hepatitis And Sexually Transmitted Infections, With The Objective Of Guaranteeing Assistance To Hiv/Aids Carriers, According To The Conditions, Specifications And Quantities Specified In The Terms Of Reference Annex I Of This Notice.
* Price Registration * Price Registration, For A Period Of One Year, And May Be Extended For The Same Period, Provided That The Advantageous Price, For Future And Eventual Acquisition Of Hiv/Aids Medicines 01
Hiv Medications
Framework Agreement With A Single Supplier For The Supply Of Medicines For Hospital Use For The Treatment Of Multiple Sclerosis And Human Immunodeficiency Virus (Hiv) Infection To The Hospitals Of The Extremadura Health Service.
Supply of Medicine and Medical / Surgical equipments : Dried Recombinant Factor, VIII Fraction\n500IU vial\nDried Recombinant Factor VIII Fraction 500IU vial\nDried factor VIII Fraction BP (Dried Recombinant\nAntihaemophilic Fraction) 500IU vial\nOR\nRecombinant Coagulation Factor VIII Ph Eur.\n500IU vial\nOR\nRecombinant Antihemophilic Factor USP 500IU vial\nOR\nDried Recombinant Antihaemophilic Fraction IP\n500IU vial\nEach vial to contain 500IU of concentrated,\npurified and viruses inactivated 3rd or 4th\ngeneration recombinant dried factor VIII Fraction\nBP, Ph Eur, USP or IP.\nNote:\n1. The item should be stable at temperature 2oC –\n8oC.\n2. The product should have minimum 24 months\nshelf life at the time of delivery to MSD.\n3. Tenderer should submit detailed specifications\nof the product offered.\n4. The product should ensure, at least two steps\non virus inactivation as recommended by\nWHO/US.FDA\n5. The purification process should be specified by\nthe manufacturer.\n6. Each batch should be certified as free from HIV\nhepatitis and other viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared by\nthe manufacturer. The test methods used should\nbe approved by WHO/US.FDA.\n8. Each vial to be supplied with suitable diluent.\n9. The product should be protected from light.\nPacking : 10 vials in a Pack etc .
Providing for for Medical Products for the ECOWAS Joint Assessment Procedure under the West Africa Medicines Regulatory Harmonization (WA-MRH)
FULL SERVICE services (with parts included), for vital signs monitors, defibrillators and ultrasound machines
Jilin Provincial Center For Disease Control And Prevention (Jilin Academy Of Preventive Medicine) Virus Institute Hiv Testing Related Reagents 36 Procurement Projects (First Package)
Annual Public Procurement Program For 2025
Provide Audit Services For The Project “Implementing Innovative Initiatives, Creating Evidence-Based Models For The National Hiv And Public Health Program And Enhancing Best Practices For Disease Control In Vietnam” For The Fiscal Year Ending December 31, 2024”
Annual Public Procurement Program For 2025
Annual Public Procurement Program For 2025
Tenders by Country